Forte Biosciences, Inc. (FBRX) Retained Earnings (Accumulated Deficit) USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Forte Biosciences, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2016 to 2024.
  • Forte Biosciences, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$126 M, a 34.3% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$126 M -$32.1 M -34.3% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$119 M -$31.5 M -36.2% Dec 31, 2023 10-Q 2024-05-13
Q3 2023 -$113 M -$30.5 M -37.1% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$103 M -$23.9 M -30.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$93.8 M -$18.1 M -23.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$87 M -$13.9 M -19% Dec 31, 2022 10-K 2024-03-18
Q3 2022 -$82.2 M -$12.3 M -17.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$78.8 M -$16.7 M -26.9% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 -$75.7 M -$19.5 M -34.6% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$73.2 M -$21.7 M -42.2% Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$69.8 M -$22.9 M -48.9% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 -$62.1 M -$20.3 M -48.6% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 -$56.3 M +$233 M +80.6% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 -$51.5 M -$46.5 M -935% Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$46.9 M +$222 M +82.6% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 -$41.8 M +$208 M +83.3% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 -$290 M -$56.7 M -24.3% Mar 31, 2020 10-Q 2020-04-23
Q4 2019 -$4.97 M +$211 M +97.7% Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$269 M -$72.5 M -37% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$250 M -$54.2 M -27.7% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 -$233 M -$53.2 M -29.6% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 -$216 M -$49 M -29.3% Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$196 M -$40.2 M -25.7% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 -$196 M -$49.8 M -34% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 -$180 M -$42.7 M -31.2% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 -$167 M -$38.9 M -30.4% Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$156 M Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$146 M Jun 30, 2017 10-Q 2017-08-09
Q1 2017 -$137 M Mar 31, 2017 10-Q 2017-05-23
Q4 2016 -$128 M Dec 31, 2016 10-K 2018-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.